Cargando…
Risk of Tuberculosis Development in Patients with Rheumatoid Arthritis Receiving Targeted Therapy: a Prospective Single Center Cohort Study
BACKGROUND: Patients with rheumatoid arthritis (RA) undergoing targeted therapy have a higher risk of developing tuberculosis (TB). This requires diagnosis and treatment of latent tuberculosis infection (LTBI). We aimed to evaluate whether diagnosis and treatment of LTBI in RA are effective in Korea...
Autores principales: | Song, Yeo-Jin, Cho, Soo-Kyung, Kim, Hyoungyoung, Kim, Hye Won, Nam, Eunwoo, Bae, Sang-Cheol, Yoo, Dae Hyun, Sung, Yoon-Kyoung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Academy of Medical Sciences
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7961872/ https://www.ncbi.nlm.nih.gov/pubmed/33724737 http://dx.doi.org/10.3346/jkms.2021.36.e70 |
Ejemplares similares
-
Factors associated with selection of targeted therapy in patients with rheumatoid arthritis
por: Song, Yeo-Jin, et al.
Publicado: (2023) -
Increased risk of herpes zoster with tofacitinib treatment in Korean patients with rheumatoid arthritis: a single-center prospective study
por: Song, Yeo-Jin, et al.
Publicado: (2023) -
Risk factors for herpes zoster in Korean patients with rheumatoid arthritis treated with JAK inhibitor: a nested case–control study
por: Song, Yeo-Jin, et al.
Publicado: (2022) -
Effectiveness of bazedoxifene in preventing glucocorticoid-induced bone loss in rheumatoid arthritis patients
por: Cho, Soo-Kyung, et al.
Publicado: (2021) -
Isoniazid treatment for latent tuberculosis infection is tolerable for rheumatoid arthritis patients receiving tumor necrosis factor inhibitor therapy
por: Sung, Yoon-Kyoung, et al.
Publicado: (2018)